An interventional study of Strawberry Beverage and Placebo in Pre-hypertension, sponsored by University of California, Davis. Completed at 1 site in United States. Open to participants aged 25 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-07-13.
Sponsored by University of California, Davis · Not applicable, Interventional, and Basic science
The specific aim of the study is to determine whether a freeze dried powder provided by the California Strawberries Commission, can reduce blood pressure in patients with pre-hypertension. The powder is prepared by the California Strawberry Commission (CSC).
Primarily, we would like to find out whether freeze dried strawberry powder lowers blood pressure. In addition we would like to know if the strawberry alters the subject's blood cholesterol and the ability of the subject's blood vessels to relax.
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 50 is below the median of 90 across 4,995 interventional studies indexed under Hypertension.
Browse Hypertension studies →University of California, Davis is the lead sponsor of 798 studies on the registry; 146 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 43 (66%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Subjects who:
The placebo beverage is matched in energy, macronutrient composition and sensory properties to the active beverage, but is devoid of strawberry polyphenols.
Other: Placebo
The strawberry beverage is matched in energy, macronutrient composition and sensory properties to the placebo beverage, but contains strawberry polyphenols.
Other: Strawberry Beverage
Beverage, daily for 8 weeks, 12g freeze-dried strawberry powder
Also known as: Strawberry powder made from a mix of California strawberries.
Placebo beverage, 8 weeks
Also known as: Beverage
Change in blood pressure
Time frame: 8 weeks
Change in low density lipoprotein (LDL) oxidation
Time frame: 8 weeks
Change in flow mediated dilation (FMD)
Time frame: 8 weeks
This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Davis